Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index; 15 of the 35 sources its claims cite were checked for support.

Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway

Open access

Abstract

Mitochondrial dysfunction and accumulation of damaged mitochondria are considered major contributors to aging. However, the molecular mechanisms responsible for these mitochondrial alterations remain unknown. Here, we demonstrate that mitofusin 2 (Mfn2) plays a key role in the control of muscle mitochondrial damage. We show that aging is characterized by a progressive reduction in Mfn2 in mouse skeletal muscle and that skeletal muscle Mfn2 ablation in mice generates a gene signature linked to aging. Furthermore, analysis of muscle Mfn2-deficient mice revealed that aging-induced Mfn2 decrease underlies the age-related alterations in metabolic homeostasis and sarcopenia. Mfn2 deficiency reduced autophagy and impaired mitochondrial quality, which contributed to an exacerbated age-related mitochondrial dysfunction. Interestingly, aging-induced Mfn2 deficiency triggers a ROS-dependent adaptive signaling pathway through induction of HIF1α transcription factor and BNIP3. This pathway compensates for the loss of mitochondrial autophagy and minimizes mitochondrial damage. Our findings reveal that Mfn2 repression in muscle during aging is a determinant for the inhibition of mitophagy and accumulation of damaged mitochondria and triggers the induction of a mitochondrial quality control pathway.

Overview

CoChat Summary

TL;DR

Mfn2 protein declines progressively in mouse skeletal muscle during aging, and muscle Mfn2 ablation reproduces and exacerbates age-related metabolic dysfunction, sarcopenia, and impaired autophagy/mitophagy. Mfn2 deficiency also triggers a ROS-dependent HIF1α–BNIP3 adaptive mitophagy pathway that mitigates mitochondrial damage.

Key findings

  • Aging is characterized by a progressive reduction in Mfn2 protein in mouse skeletal muscle at 6, 12, and 22 months, without changes in Mfn2 mRNA or polysomal mRNA, suggesting altered protein turnover.
  • Muscle Mfn2 deficiency deregulated 186 genes in young mice and 53 genes in old mice; 62% of genes deregulated in young Mfn2KO mice were also altered during normal aging, while aging changed 2,550 genes in control mice.
  • Old Mfn2KO mice showed exacerbated age-related phenotypes, including reduced mitochondrial respiration, increased H2O2 and protein carbonylation, lower muscle cross-sectional area, glucose intolerance, greater insulin levels during glucose tolerance testing, profound insulin resistance, reduced treadmill performance, and reduced grip strength.
  • Mfn2 deficiency impaired autophagy/mitophagy flux; re-expression of Mfn2 restored autophagy and increased muscle CSA. It also induced a ROS-dependent HIF1α–BNIP3 pathway: NAC blocked HIF1α/BNIP3 and worsened mitochondrial damage and muscle atrophy, while the HIF1α inhibitor NSC-134754 increased H2O2 and impaired coupled respiration in Mfn2KD cells.

Methods

  • Mouse models included Mef2C-Cre+/−Mfn2LoxP/LoxP (Mfn2KO; 80% reduction in muscle and heart, 50% in WAT, kidney, or liver) and MLC1-Cre+/−Mfn2LoxP/LoxP (SkM-KO); wild-type mice were studied at 6, 12, and 22 months, and C2C12 myotubes were used for Mfn2 knockdown.
  • Phenotyping included indirect calorimetry, glucose and insulin tolerance tests, respiration measurements in permeabilized muscle fibers/mitochondria/cells, histology and CSA quantification, fiber typing, electron microscopy, Western blotting, polysomal fractionation, SUnSET protein synthesis, proteasome activity, and mtDNA copy number.
  • Transcriptomics used Affymetrix Mouse Genome 430 2.0 arrays with GaGa differential expression and GSEA against MsigDB-C2; statistics used Student’s t-test or ANOVA with post hoc tests, significance at P < 0.05; data deposited at GEO GSE71501.

Limitations

  • No dedicated limitations section is present. The paper reports no change in lifespan in Mfn2KO mice but does not discuss this as a limitation.
  • Evident from the text: Mfn2KO is not exclusively skeletal muscle, with 80% reduction in muscle and heart and 50% in WAT, kidney, or liver, so systemic effects may contribute; SkM-KO recapitulates main features but was not characterized as extensively.
  • Evident from the text: most evidence comes from mice and C2C12 cells, with no human muscle validation, and mechanistic conclusions rely partly on pharmacological inhibitors and correlative transcriptomic analyses.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.15252/embj.201593084

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

11 Valid · 0 Not valid · 9 Not checked · 122 Own results and interpretations

78 more claims

Create a free account to see all 142 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 19
  • It may state two separate claims as one. 45

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

20 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 66 references

Cited by

See all 396

Metadata

Authors
Sebastián, D., Sorianello, E., Segalés, J., Irazoki, A., Ruiz‐Bonilla, V., Sala, D., Planet, E., Berenguer‐Llergo, A., Muñoz, J. P., Sánchez‐Feutrie, M., Plana, N., Hernández‐Álvarez, M. I., Serrano, A. L., Palacín, M., & Zorzano, A.
Affiliations
  • Instituto de Salud Carlos III (ES)
  • Institute for Research in Biomedicine (ES)
  • Universitat Pompeu Fabra (ES)
Venue
The EMBO Journal
Published
2016-06-22
Volume
35
Issue
15
Pages
1677-1693
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2461769126
Cited by
396
References
66
Citations by year
2026: 35 · 2025: 44 · 2024: 35 · 2023: 52 · 2022: 41 · 2021: 53 · 2020: 50 · 2019: 23 · 2018: 36 · 2017: 25 · 2016: 2
FWCI
14.89
Type
journal article
Language
en
Open access
Licence
Locations
  • The EMBO Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
Funders
  • Ministerio de Economía y Competitividad (SAF2013‐40987R)
  • Generalitat de Catalunya (2014SGR48)
  • European Commission (SOE1/P1/E178)
  • Instituto de Salud Carlos III (PI13/02512)
  • “María de Maeztu” Programme for Units of Excellence in R&D (MDM‐2014‐0370)
  • Association française contre les myopathies (2013‐0167/16642)
  • Fundació Marató TV3 (20144030‐31‐32)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
mitofusin 2, sarcopenia, aging, autophagy, mitophagy, mitochondrial quality control, mitochondrial dysfunction, skeletal muscle, reactive oxygen species, HIF-1α, BNIP3, metabolic homeostasis, damaged mitochondria
MeSH terms
Aging, Animals, Autophagy, Mice, Knockout, Muscle, Skeletal, GTP Phosphohydrolases, Mice, Sarcopenia, Mitophagy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway. https://app.cochat.ai/papers/10.15252/embj.201593084
The paper
Sebastián, D., Sorianello, E., Segalés, J., Irazoki, A., Ruiz‐Bonilla, V., Sala, D., Planet, E., Berenguer‐Llergo, A., Muñoz, J. P., Sánchez‐Feutrie, M., Plana, N., Hernández‐Álvarez, M. I., Serrano, A. L., Palacín, M., & Zorzano, A. (2016). Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway. The EMBO Journal. https://doi.org/10.15252/embj.201593084

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.